A carregar...

SIAXI: Placebo-controlled, randomized, double-blind study of incobotulinumtoxinA for sialorrhea

OBJECTIVE: This pivotal phase III study, SIAXI, investigated the efficacy and safety of incobotulinumtoxinA for the treatment of chronic sialorrhea due to Parkinson disease (PD), atypical parkinsonism, stroke, or traumatic brain injury (TBI). METHODS: Adult patients with PD (70.7%), atypical parkins...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Neurology
Main Authors: Jost, Wolfgang H., Friedman, Andrzej, Michel, Olaf, Oehlwein, Christian, Slawek, Jaroslaw, Bogucki, Andrzej, Ochudlo, Stanislaw, Banach, Marta, Pagan, Fernando, Flatau-Baqué, Birgit, Csikós, János, Cairney, Claire J., Blitzer, Andrew
Formato: Artigo
Idioma:Inglês
Publicado em: Lippincott Williams & Wilkins 2019
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6511076/
https://ncbi.nlm.nih.gov/pubmed/30918101
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1212/WNL.0000000000007368
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!